As international travels and destinations increase, travel-related infections increase. It is reported that 6–87% of the travellers contract travel-related infection during or after the trip. Vector-associated pathogens comprise a significant percentage of travel-related infections. Apart from the ubiquitous COVID19, threats such as Dengue, Chikungunya and Zika virus and tick-borne agents have emerged or re-emerged in recent years. The fact that these infections are carried with similar vectors and cause similar symptoms makes diagnosis difficult. Herein, a case of travel-associated infection with nonspecific symptoms is presented.
Gul HC and Erdem H. Brucella species. In: Bennett JE, Dolin R and Blaser MJ (eds) Principles and practice of infectious diseases. Vol. 318. 9th ed. Philadelphia, PA: Elsevier, 2020, pp.3818–3827.
2.
Kristina MA, Phyllis EK, Edward TR, et al. What proportion of international travellers acquire a travel related illness? A review of the literatüre. J Travel Med 2017; 1; 24.
3.
PepeFAkıncıEBodurH. What to know about travel related infections. Mediterr J Infect Microb Antimicrob2018; 7: 1–1.
4.
Panamerican Health Organization – World Health Organization Guidelines for the serologic diagnosis of Zika Virus, 2016, www.paho.org/hq/dmdocuments/2016/Guidelines – serological-diagnosis-of-ZIKV-infection-October-2016.pdf (2016, accessed 18 May 2020).
